| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $242,021,657 ) (Continued on the next page) |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01NS118786 | CaMKII in global cerebral ischemia: mechanisms and therapeutic intervention | 001 | 4 | NIH | 5/3/2024 | $27,213 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF COLORADO, THE | 13001 E 17TH PLACE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01NS118786 | CaMKII in global cerebral ischemia: mechanisms and therapeutic intervention | 000 | 4 | NIH | 12/7/2023 | $349,875 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R00GM141453 | Imaging cotranslational protein folding with high spatiotemporal resolution in living cells | 002 | 4 | NIH | 7/15/2024 | $24,900 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | F31NS120422 | CD38 activation of TRPM2 in hippocampal neurons contributes to stroke-induced cognitive dysfunction | 003 | 3 | NIH | 6/14/2024 | $1,280 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | F31NS120422 | CD38 activation of TRPM2 in hippocampal neurons contributes to stroke-induced cognitive dysfunction | 001 | 2 | NIH | 1/5/2024 | $2,500 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF COLORADO, THE | 13001 E 17TH PLACE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | F31NS120422 | CD38 activation of TRPM2 in hippocampal neurons contributes to stroke-induced cognitive dysfunction | 000 | 3 | NIH | 12/28/2023 | $40,346 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | F31NS120422 | CD38 activation of TRPM2 in hippocampal neurons contributes to stroke-induced cognitive dysfunction | 002 | 3 | NIH | 1/19/2024 | $2,500 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R00GM141453 | Imaging cotranslational protein folding with high spatiotemporal resolution in living cells | 001 | 4 | NIH | 1/23/2024 | $224,099 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF COLORADO, THE | 13001 E 17TH PLACE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01MH124778 | Serotonergic modulation of excitatory synapse formation and maturation during development | 000 | 4 | NIH | 12/14/2023 | $345,330 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01CA239093 | Discovery and therapeutic targeting of biological determinants of lung cancer health disparities | 001 | 5 | NIH | 4/24/2024 | $23,219 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01CA239093 | Discovery and therapeutic targeting of biological determinants of lung cancer health disparities | 000 | 5 | NIH | 1/29/2024 | $417,950 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01DK124901 | A Novel Driver of Hyperphosphatemia and Vascular Calcification in CKD | 001 | 4 | NIH | 5/20/2024 | $29,318 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF COLORADO, THE | 13001 E 17TH PLACE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01DK124901 | A Novel Driver of Hyperphosphatemia and Vascular Calcification in CKD | 000 | 4 | NIH | 11/29/2023 | $439,770 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R25HL161713 | The Colorado Summer Institute for Research Education in Biostatistics (CoSIBS) | 000 | 3 | NIH | 1/8/2024 | $242,299 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01HL151331 | PTEN promoter hypermethylation underlies vascular disease progression | 001 | 4 | NIH | 6/13/2024 | $45,895 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF COLORADO, THE | 13001 E 17TH PLACE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01HL151331 | PTEN promoter hypermethylation underlies vascular disease progression | 000 | 4 | NIH | 12/29/2023 | $516,321 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01HL156670 | Targeting Mitochondria in Single Ventricle Heart Disease | 003 | 4 | NIH | 6/12/2024 | $53,192 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01HL156670 | Targeting Mitochondria in Single Ventricle Heart Disease | 002 | 4 | NIH | 6/7/2024 | -$74,030 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF COLORADO, THE | 13001 E 17TH PLACE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01HL156670 | Targeting Mitochondria in Single Ventricle Heart Disease | 000 | 4 | NIH | 12/25/2023 | $598,412 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF COLORADO, THE | 13001 E 17TH PLACE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01HL156670 | Targeting Mitochondria in Single Ventricle Heart Disease | 001 | 4 | NIH | 12/27/2023 | $161,134 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01DK126710 | Dietary influence on infant growth and the gut microbiota | 001 | 4 | NIH | 5/20/2024 | $39,015 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01DK126710 | Dietary influence on infant growth and the gut microbiota | 000 | 4 | NIH | 1/10/2024 | $585,202 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01DK131196 | Discovering the Mechanism of Action of a peptide drug, OPT101, that targets CD40 mediated inflammation in type 1 diabetes | 001 | 3 | NIH | 5/3/2024 | $26,403 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R21DC019169 | Host factors influencing early clearance of Streptococcus pneumoniae from the middle ear following invasion from the nasopharynx | 001 | 3 | NIH | 5/2/2024 | $19,437 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R21DC019169 | Host factors influencing early clearance of Streptococcus pneumoniae from the middle ear following invasion from the nasopharynx | 000 | 3 | NIH | 1/10/2024 | $174,938 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01NR019782 | A mixed-methods study of the nature, extent and consequences of artificial intelligence (AI) for individualized treatment planning in end-of-life and palliative care (EOLPC) | 001 | 3 | NIH | 5/3/2024 | $63,857 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01NR019782 | A mixed-methods study of the nature, extent and consequences of artificial intelligence (AI) for individualized treatment planning in end-of-life and palliative care (EOLPC) | 000 | 3 | NIH | 1/16/2024 | $574,721 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01DK131196 | Discovering the Mechanism of Action of a peptide drug, OPT101, that targets CD40 mediated inflammation in type 1 diabetes | 000 | 3 | NIH | 1/24/2024 | $396,060 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF COLORADO, THE | 13001 E 17TH PLACE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | K23HL161354 | Novel Markers of Treatment Responsiveness for Pediatric Acute Asthma Exacerbations | 000 | 3 | NIH | 12/1/2023 | $184,470 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01DK123334 | Breaking up sedentary behaviors to improve glucose control in a population at risk for developing type 2 diabetes | 001 | 4 | NIH | 5/7/2024 | $35,308 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF COLORADO, THE | 13001 E 17TH PLACE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01DK123334 | Breaking up sedentary behaviors to improve glucose control in a population at risk for developing type 2 diabetes | 000 | 4 | NIH | 12/15/2023 | $529,636 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | F31NS130940 | Meninges Specification and Cellular Crosstalk to the Developing Brain | 002 | 2 | NIH | 6/17/2024 | $1,280 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF COLORADO, THE | 13001 E 17TH PLACE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | F31NS130940 | Meninges Specification and Cellular Crosstalk to the Developing Brain | 001 | 2 | NIH | 12/4/2023 | $38,955 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | D4033359 | Graduate Psychology Education Programs | 00 | 6 | HRSA | 6/5/2024 | $72,436 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | D4033359 | Graduate Psychology Education Programs | 00 | 6 | HRSA | 6/5/2024 | $217,307 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | 2401COATSG | FY2024 (ATSG) AT Act State Grants for Assistive Technology | 3 | 1 | ACL | 5/20/2024 | $292,409 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | 2401COATSG | FY2024 (ATSG) AT Act State Grants for Assistive Technology | 2 | 1 | ACL | 3/15/2024 | $74,500 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | 2401COATSG | FY2024 (ATSG) AT Act State Grants for Assistive Technology | 1 | 1 | ACL | 12/12/2023 | $117,063 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | 2401COATSG | FY2024 (ATSG) AT Act State Grants for Assistive Technology | 0 | 1 | ACL | 10/30/2023 | $72,942 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01AR083381 | Mechanisms of DUX4-induced misregulation of RNA processing and quality control | 000 | 1 | NIH | 7/23/2024 | $522,001 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R21DC022075 | Development of human taste organoid models | 000 | 1 | NIH | 7/23/2024 | $429,000 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | F31AI181452 | Induction of tolerance to a Hybrid Insulin Peptide and the impact on autoreactive T cell fate and function in autoimmune diabetic islet transplant | 000 | 1 | NIH | 7/22/2024 | $39,897 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R21TR004695 | Clinical Trial Readiness for Posterior Cortical Atrophy Syndrome | 000 | 1 | NIH | 7/22/2024 | $429,000 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | T3242016 | NRSA for Primary Medical Care | 00 | 4 | HRSA | 7/2/2024 | $458,822 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | M0141984 | Behavioral Health Workforce Education and Training Program | 00 | 4 | HRSA | 6/17/2024 | $479,988 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | F31DE032592 | Assessing TGF Beta1-Mediated ECM Remodeling in Metastatic Oral Squamous Cell Carcinoma | 001 | 2 | NIH | 6/11/2024 | $1,280 |
| 2024 | 2024 | REGENTS OF THE UNIVERSITY OF COLORADO, THE | 13001 E 17TH PLACE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | F31DE032592 | Assessing TGF Beta1-Mediated ECM Remodeling in Metastatic Oral Squamous Cell Carcinoma | 000 | 2 | NIH | 11/8/2023 | $44,014 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01AI177445 | Molecular Mechanism of an Exporter-like ABC Importer YbtPQ | 000 | 1 | NIH | 7/17/2024 | $449,282 |
| 2024 | 2024 | THE REGENTS OF THE UNIVERSITY OF COLORADO | 13001 E 17TH PL STE F428 | AURORA | CO | 80045-2571 | ADAMS | USA | R01HL161004 | The paradoxical response to iron in pulmonary hypertension of sickle cell disease | 001 | 3 | NIH | 6/21/2024 | $53,642 |
|